Companies / Kymera Therapeutics, Inc. / Activity
Activity — Kymera Therapeutics, Inc.
11 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Algert Global LLC 13F manager | New | Common stock | $402 | +5K | 4,830 <0.01% of shares | low |
| Q1 2026 as of | Marquette Asset Management, LLC 13F manager | New | Common stock | $500 | +6 | 6 <0.01% of shares | low |
| Q1 2026 as of | Gsa Capital Partners LLP 13F manager | New | Common stock | $1.1K | +13K | 12,657 0.02% of shares | low |
| Q1 2026 as of | MassMutual Private Wealth & Trust, FSB 13F manager | New | Common stock | $2.3K | +28 | 28 <0.01% of shares | low |
| Q4 2022 as of | Leonteq Securities AG 13F manager | New | Common stock | $73.8K | +3K | 2,955 <0.01% of shares | low |
| Q4 2021 as of | Leonteq Securities AG 13F manager | New | Common stock | $247.1K | +4K | 3,892 <0.01% of shares | low |
| Q1 2026 as of | Amundi 13F manager | New | Common stock | $248.9K | +3K | 2,988 <0.01% of shares | low |
| Q1 2026 as of | Hudson Bay Capital Management LP 13F manager | New | Common stock | $309.0K | +4K | 3,710 <0.01% of shares | low |
| Q1 2026 as of | Blackstone Inc 13F manager | New | Common stock | $554.7K | +7K | 6,660 <0.01% of shares | low |
| Q1 2026 as of | Brandywine Managers, LLC 13F manager | New | Common stock | $630.5K | +8K | 7,570 <0.01% of shares | low |
| Q2 2026 as of | LPL Financial LLC 13F manager | New | Common stock | $1.20M | +10K | 10,481 0.01% of shares | low |